Compare Biocon with Lupin - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LUPIN BIOCON /
LUPIN
 
P/E (TTM) x 39.8 -17.8 - View Chart
P/BV x 5.2 2.0 264.5% View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 BIOCON    LUPIN
EQUITY SHARE DATA
    BIOCON
Mar-21
LUPIN
Mar-21
BIOCON /
LUPIN
5-Yr Chart
Click to enlarge
High Rs4881,122 43.5%   
Low Rs275576 47.7%   
Sales per share (Unadj.) Rs59.2334.2 17.7%  
Earnings per share (Unadj.) Rs7.727.0 28.5%  
Cash flow per share (Unadj.) Rs13.746.6 29.3%  
Dividends per share (Unadj.) Rs06.50 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs62.3300.1 20.8%  
Shares outstanding (eoy) m1,200.00453.68 264.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.42.5 253.4%   
Avg P/E ratio x49.431.4 157.4%  
P/CF ratio (eoy) x27.918.2 153.1%  
Price / Book Value ratio x6.12.8 216.4%  
Dividend payout %024.0 0.0%   
Avg Mkt Cap Rs m457,350385,072 118.8%   
No. of employees `000NANA-   
Total wages/salary Rs m17,41028,259 61.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m71,058151,630 46.9%  
Other income Rs m6,0521,363 444.1%   
Total revenues Rs m77,110152,993 50.4%   
Gross profit Rs m13,14525,669 51.2%  
Depreciation Rs m7,1518,874 80.6%   
Interest Rs m5771,406 41.0%   
Profit before tax Rs m11,46916,751 68.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2154,485 49.4%   
Profit after tax Rs m9,25412,266 75.4%  
Gross profit margin %18.516.9 109.3%  
Effective tax rate %19.326.8 72.1%   
Net profit margin %13.08.1 161.0%  
BALANCE SHEET DATA
Current assets Rs m76,004139,864 54.3%   
Current liabilities Rs m42,10184,361 49.9%   
Net working cap to sales %47.736.6 130.3%  
Current ratio x1.81.7 108.9%  
Inventory Days Days13769 197.4%  
Debtors Days Days63108 58.1%  
Net fixed assets Rs m106,14294,439 112.4%   
Share capital Rs m6,000907 661.2%   
"Free" reserves Rs m68,728135,229 50.8%   
Net worth Rs m74,728136,136 54.9%   
Long term debt Rs m29,616161 18,372.2%   
Total assets Rs m182,146234,302 77.7%  
Interest coverage x20.912.9 161.7%   
Debt to equity ratio x0.40 33,469.7%  
Sales to assets ratio x0.40.6 60.3%   
Return on assets %5.45.8 92.5%  
Return on equity %12.49.0 137.4%  
Return on capital %11.513.3 86.7%  
Exports to sales %00-   
Imports to sales %7.20-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m5,084NA-   
Fx inflow Rs m11,79151,027 23.1%   
Fx outflow Rs m5,08421,081 24.1%   
Net fx Rs m6,70729,946 22.4%   
CASH FLOW
From Operations Rs m11,59718,218 63.7%  
From Investments Rs m-36,247-12,396 292.4%  
From Financial Activity Rs m25,640-18,853 -136.0%  
Net Cashflow Rs m723-13,031 -5.5%  

Share Holding

Indian Promoters % 39.7 46.5 85.4%  
Foreign collaborators % 20.9 0.3 7,467.9%  
Indian inst/Mut Fund % 24.0 41.9 57.3%  
FIIs % 15.6 14.7 106.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 53.2 74.0%  
Shareholders   347,911 378,547 91.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

Sensex, Nifty End Lower as Realty & IT Stocks Witness Selling; Asian Paints, Berger Paints Slump 8%(Closing)

After opening on a positive note, Indian share markets failed to hold early gains and ended the day lower.

Related Views on News

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


May 25, 2022 (Close)

TRACK BIOCON

BIOCON - BAL PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS